Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 1
1953 2
1954 1
1958 1
1965 1
1967 1
1969 1
1972 1
2002 1
2003 4
2004 4
2005 5
2006 9
2007 5
2008 3
2009 8
2010 7
2011 7
2012 5
2014 2
2015 1
2016 2
2017 1
2018 1
2019 1
2020 1
2022 1
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial.
Goldschmidt H, Mai EK, Bertsch U, Fenk R, Nievergall E, Tichy D, Besemer B, Dürig J, Schroers R, von Metzler I, Hänel M, Mann C, Asemissen AM, Heilmeier B, Weinhold N, Huhn S, Kriegsmann K, Luntz SP, Holderried TAW, Trautmann-Grill K, Gezer D, Klaiber-Hakimi M, Müller M, Khandanpour C, Knauf W, Scheid C, Munder M, Geer T, Riesenberg H, Thomalla J, Hoffmann M, Raab MS, Salwender HJ, Weisel KC; German-Speaking Myeloma Multicenter Group (GMMG) HD7 investigators. Goldschmidt H, et al. Lancet Haematol. 2022 Nov;9(11):e810-e821. doi: 10.1016/S2352-3026(22)00263-0. Lancet Haematol. 2022. PMID: 36328040 Clinical Trial.
[Malignant epibulbar tumours: new strategies in diagnostics and therapy].
Westekemper H, Schallenberg M, Tomaszewski A, Nückel H, Sauerwein W, Meller D, Steuhl K. Westekemper H, et al. Among authors: nuckel h. Klin Monbl Augenheilkd. 2011 Sep;228(9):780-92. doi: 10.1055/s-0029-1246068. Epub 2011 Apr 12. Klin Monbl Augenheilkd. 2011. PMID: 21487989 Review. German.
Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6): results from a randomised, phase 3 trial.
Mai EK, Goldschmid H, Miah K, Bertsch U, Besemer B, Hänel M, Krzykalla J, Fenk R, Schlenzka J, Munder M, Dürig J, Blau IW, Huhn S, Hose D, Jauch A, Kunz C, Mann C, Weinhold N, Scheid C, Schroers R, von Metzler I, Schieferdecker A, Thomalla J, Reimer P, Mahlberg R, Graeven U, Kremers S, Martens UM, Kunz C, Hensel M, Benner A, Seidel-Glätzer A, Weisel KC, Raab MS, Salwender HJ; German-speaking Myeloma Multicenter Group (GMMG) HD6 investigators. Mai EK, et al. Lancet Haematol. 2024 Feb;11(2):e101-e113. doi: 10.1016/S2352-3026(23)00366-6. Lancet Haematol. 2024. PMID: 38302221 Free article. Clinical Trial.
p53 protein expression in chronic lymphocytic leukemia.
Sellmann L, Carpinteiro A, Nückel H, Scholtysik R, Siemer D, Klein-Hipass L, Kube D, Dürig J, Dührsen U, Stanelle J, Küppers R. Sellmann L, et al. Among authors: nuckel h. Leuk Lymphoma. 2012 Jul;53(7):1282-8. doi: 10.3109/10428194.2011.654115. Epub 2012 Feb 13. Leuk Lymphoma. 2012. PMID: 22220854
Telomeres and prognosis in patients with chronic lymphocytic leukaemia.
Sellmann L, de Beer D, Bartels M, Opalka B, Nückel H, Dührsen U, Dürig J, Seifert M, Siemer D, Küppers R, Baerlocher GM, Röth A. Sellmann L, et al. Among authors: nuckel h. Int J Hematol. 2011 Jan;93(1):74-82. doi: 10.1007/s12185-010-0750-2. Epub 2011 Jan 5. Int J Hematol. 2011. PMID: 21203871
Prognostic significance of serum cystatin C in multiple myeloma.
Nückel H, Langer C, Herget-Rosenthal S, Wichert M, Assert R, Döhner H, Dührsen U, Liebisch P. Nückel H, et al. Int J Hematol. 2012 May;95(5):545-50. doi: 10.1007/s12185-012-1049-2. Epub 2012 Mar 18. Int J Hematol. 2012. PMID: 22426688
72 results